PortfoliosLab logoPortfoliosLab logo
CURE vs. QQQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CURE vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Invesco QQQ ETF (QQQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -18.38% return, which is significantly lower than QQQ's 21.30% return. Over the past 10 years, CURE has underperformed QQQ with an annualized return of 11.65%, while QQQ has yielded a comparatively higher 21.94% annualized return.


CURE

1D
2.17%
1M
4.39%
YTD
-18.38%
6M
-18.70%
1Y
21.60%
3Y*
-0.15%
5Y*
0.21%
10Y*
11.65%

QQQ

1D
-0.26%
1M
10.60%
YTD
21.30%
6M
19.66%
1Y
41.82%
3Y*
28.78%
5Y*
17.97%
10Y*
21.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. QQQ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
-18.38%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%
QQQ
Invesco QQQ ETF
21.30%20.77%25.58%54.86%-32.58%27.42%48.62%38.96%-0.13%32.66%

Correlation

The correlation between CURE and QQQ is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.44

Correlation (10Y)
Calculated over the trailing 10-year period

0.54

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2011

0.60

Over the past year, the correlation between CURE and QQQ has dropped to 0.18 - well below their long-term average of 0.60, suggesting their price drivers have been diverging.

CURE vs. QQQ - Sectors Allocation Comparison


Sectors
CURE
QQQ

Healthcare

100.0%
4.2%

Basic Materials

-

1.1%

Communication Services

-

15.8%

Consumer Cyclical

-

12.3%

Consumer Defensive

-

7.7%

Energy

-

0.6%

Financial Services

-

0.2%

Industrials

-

2.8%

Real Estate

-

0.1%

Technology

-

53.8%

Utilities

-

1.4%

Healthcare

CURE
100.0%
QQQ
4.2%

Basic Materials

CURE

-

QQQ
1.1%

Communication Services

CURE

-

QQQ
15.8%

Consumer Cyclical

CURE

-

QQQ
12.3%

Consumer Defensive

CURE

-

QQQ
7.7%

Energy

CURE

-

QQQ
0.6%

Financial Services

CURE

-

QQQ
0.2%

Industrials

CURE

-

QQQ
2.8%

Real Estate

CURE

-

QQQ
0.1%

Technology

CURE

-

QQQ
53.8%

Utilities

CURE

-

QQQ
1.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CURE vs. QQQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE
CURE Risk / Return Rank: 1818
Overall Rank
CURE Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 1919
Sortino Ratio Rank
CURE Omega Ratio Rank: 1818
Omega Ratio Rank
CURE Calmar Ratio Rank: 1717
Calmar Ratio Rank
CURE Martin Ratio Rank: 1717
Martin Ratio Rank

QQQ
QQQ Risk / Return Rank: 7373
Overall Rank
QQQ Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
QQQ Sortino Ratio Rank: 7575
Sortino Ratio Rank
QQQ Omega Ratio Rank: 7474
Omega Ratio Rank
QQQ Calmar Ratio Rank: 6969
Calmar Ratio Rank
QQQ Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. QQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CUREQQQDifference
Sharpe ratioReturn per unit of total volatility

-2.14

Sortino ratioReturn per unit of downside risk

-2.41

Omega ratioGain probability vs. loss probability

1.12

1.45

-0.34

Calmar ratioReturn relative to maximum drawdown

0.70

3.51

-2.81

Martin ratioReturn relative to average drawdown

1.61

13.49

-11.88

CURE vs. QQQ - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.50, which is lower than the QQQ Sharpe Ratio of 2.64. The chart below compares the historical Sharpe Ratios of CURE and QQQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CUREQQQDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.50

2.64

-2.14

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.00

0.81

-0.80

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.24

0.99

-0.75

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

0.41

+0.05

Drawdowns

CURE vs. QQQ - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum QQQ drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for CURE and QQQ.


Loading charts...

Drawdown Indicators


CUREQQQDifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-82.97%

+13.78%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-11.96%

-19.14%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-22.77%

-29.16%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-35.12%

-17.11%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

-35.12%

-34.07%

Current Drawdown

Current decline from peak

-35.21%

-0.26%

-34.95%

Average Drawdown

Average peak-to-trough decline

-18.15%

-32.79%

+14.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.43%

3.11%

+10.32%

Volatility

CURE vs. QQQ - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 11.99% compared to Invesco QQQ ETF (QQQ) at 4.49%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CUREQQQDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.99%

4.49%

+7.50%

Volatility (6M)

Calculated over the trailing 6-month period

29.83%

12.10%

+17.73%

Volatility (1Y)

Calculated over the trailing 1-year period

43.19%

15.94%

+27.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.69%

22.38%

+21.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.51%

22.29%

+27.22%

CURE vs. QQQ - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than QQQ's 0.18% expense ratio.


Dividends

CURE vs. QQQ - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.31%, more than QQQ's 0.38% yield.


PositionTTM20252024202320222021202020192018201720162015
CURE
Direxion Daily Healthcare Bull 3x Shares
1.31%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%
QQQ
Invesco QQQ ETF
0.38%0.45%0.56%0.62%0.80%0.43%0.55%0.74%0.91%0.84%1.06%0.99%

Frequently Asked Questions


CURE and QQQ have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (11.99%) compared to QQQ (4.49%). In terms of maximum drawdown, CURE dropped -69.19% vs QQQ's -82.97%.

On 10-year performance, QQQ leads with 21.94% vs 11.65% for CURE. On fees, QQQ is cheaper at 0.18% per year. On volatility, QQQ has been the lower-risk option at 4.49%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, QQQ has performed better with a 21.94% return vs 11.65%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

QQQ is cheaper with a 0.18% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.31%, compared with 0.38% for QQQ.

CURE is categorized as Leveraged Equities, while QQQ is Nasdaq-100. CURE tracks Health Care Select Sector Index (300%), while QQQ tracks NASDAQ-100 Index. They also come from different issuers: Direxion and Invesco. Their fees differ too: 1.08% for CURE and 0.18% for QQQ.

QQQ currently has the higher Sharpe Ratio (2.64 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and QQQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer